Platelet-Rich Plasma for Intra-articular Injections: Preclinical and Clinical Evidence
- PMID: 36355307
- DOI: 10.1007/978-1-0716-2839-3_28
Platelet-Rich Plasma for Intra-articular Injections: Preclinical and Clinical Evidence
Abstract
The use of platelet-rich plasma (PRP) has been supported by encouraging data from in vitro and preclinical in vivo studies, both in terms of safety and efficacy. This led to the wide use of PRP injections in the clinical practice, with promising results especially as a minimally invasive treatment for cartilage degeneration and osteoarthritis (OA). While many controversies remain on the best PRP formulation, the overall available clinical studies support the benefits of PRP, with functional improvement and reduction of pain-related symptoms up to 12 months, especially in young patients and early OA stages.
Keywords: Cartilage; Injection; Intra-articular; Osteoarthritis; PRP; Platelet-rich plasma.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Ayhan E, Kesmezacar H, Akgun I (2014) Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop 5(3):351–361. https://doi.org/10.5312/wjo.v5.i3.351 - DOI
-
- Crawford DC, Miller LE, Block JE (2013) Conservative management of symptomatic knee osteoarthritis: a flawed strategy? Orthop Rev 5(1):e2. https://doi.org/10.4081/or.2013.e2 - DOI
-
- Jevsevar DS (2013) Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 21(9):571–576. https://doi.org/10.5435/JAAOS-21-09-571 - DOI
-
- Bannuru RR, Osani MC, Vaysbrot EE et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil 27(11):1578–1589. https://doi.org/10.1016/j.joca.2019.06.011 - DOI
-
- Bruyere O, Honvo G, Veronese N et al (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 49(3):337–350. https://doi.org/10.1016/j.semarthrit.2019.04.008 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
